|
|
| G
|
Abhd11-as1
|
ABHD11 antisense RNA 1
|
increases expression
|
ISO
|
Propofol results in increased expression of BICDL3P mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr12:27,317,656...27,318,643
|
|
| G
|
Acta1
|
actin, alpha 1, skeletal muscle
|
multiple interactions
|
EXP
|
HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]
|
CTD |
PMID:24810525 |
|
NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions increases phosphorylation decreases phosphorylation
|
EXP ISO
|
Propofol promotes the reaction [Streptozocin results in decreased phosphorylation of AKT1 protein] Propofol results in increased phosphorylation of AKT1 protein Propofol results in decreased phosphorylation of AKT1 protein CASC9 protein inhibits the reaction [Propofol results in decreased phosphorylation of AKT1 protein]
|
CTD |
PMID:24810525 PMID:35238236 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
decreases expression multiple interactions
|
EXP
|
Propofol results in decreased expression of APAF1 protein Propofol inhibits the reaction [Doxorubicin results in increased expression of APAF1 protein]
|
CTD |
PMID:21468576 PMID:22015447 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Arc
|
activity-regulated cytoskeleton-associated protein
|
multiple interactions decreases expression
|
EXP
|
Bicuculline inhibits the reaction [Propofol results in decreased expression of ARC protein]
|
CTD |
PMID:18946287 |
|
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220
|
|
| G
|
Avp
|
arginine vasopressin
|
multiple interactions
|
ISO
|
[Propofol co-treated with desflurane] results in increased expression of AVP protein
|
CTD |
PMID:8017643 |
|
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:138,246,554...138,248,522
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression decreases expression
|
EXP ISO
|
[Resveratrol co-treated with Propofol] results in decreased expression of BAX; NUFIP1 protein affects the reaction [Propofol results in increased expression of BAX protein]; PEA15 protein inhibits the reaction [Propofol results in increased expression of BAX protein]; Propofol inhibits the reaction [Doxorubicin results in increased expression of BAX protein] Propofol results in decreased expression of BAX [NUFIP1 affects the susceptibility to Propofol] which affects the expression of BAX protein; Acetylcysteine inhibits the reaction [Propofol results in increased expression of BAX protein]
|
CTD |
PMID:21786383 PMID:22015447 PMID:23353162 PMID:28804952 PMID:31257496 PMID:38599287 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
increases expression multiple interactions decreases expression
|
EXP ISO
|
Propofol results in increased expression of BCL2; Propofol results in increased expression of BCL2 mRNA; Propofol results in increased expression of BCL2 protein [Resveratrol co-treated with Propofol] results in increased expression of BCL2; NUFIP1 protein affects the reaction [Propofol results in decreased expression of BCL2 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased expression of BCL2 protein]; Propofol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]; Propofol inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]; Wortmannin inhibits the reaction [Propofol results in increased expression of BCL2 protein] [NUFIP1 affects the susceptibility to Propofol] which affects the expression of BCL2 protein; Acetylcysteine inhibits the reaction [Propofol results in decreased expression of BCL2 protein]
|
CTD |
PMID:19703415 PMID:21786383 PMID:22015447 PMID:23353162 PMID:24810525 PMID:28804952 PMID:31257496 PMID:38599287 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
decreases expression
|
EXP
|
Propofol results in decreased expression of BCL2L1 mRNA; Propofol results in decreased expression of BCL2L1 protein
|
CTD |
PMID:26254736 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Becn1
|
beclin 1
|
increases expression multiple interactions
|
ISO
|
Propofol results in increased expression of BECN1 protein MIR138 promotes the reaction [Propofol results in increased expression of BECN1 protein]
|
CTD |
PMID:39441175 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Blacat1
|
BLACAT1 overlapping LEMD1 locus
|
increases expression
|
ISO
|
Propofol results in increased expression of BLACAT1 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr13:46,189,091...46,202,506
Ensembl chr13:46,197,208...46,197,306
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
multiple interactions
|
ISO
|
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of BNIP3 mRNA]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of BNIP3 protein]
|
CTD |
PMID:21307008 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
C17h10orf67
|
similar to human chromosome 10 open reading frame 67
|
increases expression
|
ISO
|
Propofol results in increased expression of C10ORF67 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr17:86,970,801...87,082,723
Ensembl chr17:86,980,186...87,082,700
|
|
| G
|
C1h10orf143
|
similar to human chromosome 10 open reading frame 143
|
decreases expression
|
ISO
|
Propofol results in decreased expression of C10ORF143 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 1:201,614,151...201,654,142
Ensembl chr 1:201,561,396...201,652,127
|
|
| G
|
C3
|
complement C3
|
multiple interactions
|
ISO
|
[Triglycerides co-treated with Propofol] results in increased expression of C3 protein modified form
|
CTD |
PMID:15983144 |
|
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
Ca1
|
carbonic anhydrase 1
|
decreases activity
|
ISO
|
Propofol analog results in decreased activity of CA1 protein; Propofol results in decreased activity of CA1 protein
|
CTD |
PMID:19231207 |
|
NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:88,495,475...88,593,454
|
|
| G
|
Ca5a
|
carbonic anhydrase 5A
|
decreases expression
|
ISO
|
Propofol results in decreased expression of CA5A mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr19:66,881,678...66,911,486
Ensembl chr19:66,881,693...66,911,486
|
|
| G
|
Cacna1i
|
calcium voltage-gated channel subunit alpha1 I
|
affects response to substance
|
EXP
|
CACNA1I protein affects the susceptibility to Propofol
|
CTD |
PMID:15644869 |
|
NCBI chr 7:113,716,266...113,827,670
Ensembl chr 7:113,716,266...113,827,670
|
|
| G
|
Car2
|
carbonic anhydrase 2
|
decreases activity
|
ISO
|
Propofol analog results in decreased activity of CA2 protein; Propofol results in decreased activity of CA2 protein
|
CTD |
PMID:19231207 |
|
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases activity decreases expression increases expression increases cleavage
|
EXP ISO
|
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole promotes the reaction [Propofol results in increased cleavage of CASP3 protein]; [Resveratrol co-treated with Propofol] results in decreased expression of CASP3; calpeptin inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; hyperforin inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; NUFIP1 protein inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased expression of CASP3 protein]; PEA15 protein inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; Propofol inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Propofol inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Propofol inhibits the reaction [Streptozocin results in increased cleavage of CASP3 protein]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]] Propofol results in increased activity of CASP3 protein Propofol results in decreased expression of CASP3; Propofol results in decreased expression of CASP3 protein Propofol results in increased expression of CASP3 protein modified form Acetylcysteine inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]
|
CTD |
PMID:17640472 PMID:21786383 PMID:22015447 PMID:23353162 PMID:24810525 PMID:26254736 PMID:28804952 PMID:31257496 PMID:36640868 PMID:38599287 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
decreases cleavage increases activity increases cleavage multiple interactions
|
EXP ISO
|
Propofol results in decreased cleavage of CASP9 protein Propofol results in increased activity of CASP9 protein Propofol results in increased cleavage of CASP9 protein Acetylcysteine inhibits the reaction [Propofol results in increased cleavage of CASP9 protein]
|
CTD |
PMID:21468576 PMID:21786383 PMID:28804952 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
increases expression multiple interactions decreases activity
|
ISO EXP
|
Propofol results in increased expression of CAT protein Acetylcysteine inhibits the reaction [Propofol results in decreased activity of CAT protein]
|
CTD |
PMID:16938161 PMID:21468576 PMID:28804952 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccdc196
|
coiled-coil domain containing 196
|
affects expression
|
ISO
|
Propofol affects the expression of CCDC196 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 6:102,646,156...102,672,145
Ensembl chr 6:102,648,953...102,664,225
|
|
| G
|
Ccnb1
|
cyclin B1
|
decreases expression
|
ISO
|
Propofol results in decreased expression of CCNB1 protein
|
CTD |
PMID:28804952 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Ccnd1
|
cyclin D1
|
increases expression
|
ISO
|
Propofol results in increased expression of CCND1 protein
|
CTD |
PMID:28804952 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Cd68
|
Cd68 molecule
|
increases expression multiple interactions
|
ISO
|
Propofol results in increased expression of CD68 mRNA Lipopolysaccharides inhibits the reaction [Propofol results in increased expression of CD68 mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540
|
|
| G
|
Cdh1
|
cadherin 1
|
multiple interactions
|
ISO
|
Propofol affects the reaction [LINC01133 affects the expression of CDH1 protein]
|
CTD |
PMID:38146619 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cdh11
|
cadherin 11
|
multiple interactions
|
ISO
|
Propofol inhibits the reaction [Lipopolysaccharides results in decreased expression of CDH11 mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr19:2,152,961...2,312,140
Ensembl chr19:2,154,840...2,312,140
|
|
| G
|
Cdh2
|
cadherin 2
|
multiple interactions
|
ISO
|
Propofol affects the reaction [LINC01133 affects the expression of CDH2 protein]
|
CTD |
PMID:38146619 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
| G
|
Cdk1
|
cyclin-dependent kinase 1
|
decreases expression multiple interactions
|
ISO
|
Propofol results in decreased expression of CDK1 protein [Propofol results in increased susceptibility to STA 9090] which results in decreased expression of CDK1 protein
|
CTD |
PMID:24784839 PMID:28804952 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
| G
|
Cdk5r1
|
cyclin-dependent kinase 5 regulatory subunit 1
|
multiple interactions increases expression
|
EXP
|
Dexmedetomidine inhibits the reaction [Propofol results in increased expression of CDK5R1 protein]
|
CTD |
PMID:31187143 |
|
NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272
|
|
| G
|
Chrm1
|
cholinergic receptor, muscarinic 1
|
multiple interactions
|
EXP
|
Propofol inhibits the reaction [Acetylcholine results in increased activity of CHRM1 protein]; Propofol inhibits the reaction [Scopolamine Derivatives results in increased activity of CHRM1 protein]
|
CTD |
PMID:14534362 |
|
NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:214,995,872...215,020,602
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
decreases phosphorylation multiple interactions
|
EXP
|
Propofol results in decreased phosphorylation of CREB1 protein PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of CREB1 protein]
|
CTD |
PMID:31257496 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
decreases expression
|
ISO
|
Propofol results in decreased expression of CXCL12 protein
|
CTD |
PMID:36207479 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cxcl3
|
C-X-C motif chemokine ligand 3
|
multiple interactions
|
ISO
|
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA]
|
CTD |
PMID:21307008 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
|
|
| G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
decreases expression
|
ISO
|
Propofol results in decreased expression of CXCR4 protein
|
CTD |
PMID:36207479 |
|
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
increases expression
|
ISO
|
Propofol results in increased expression of CYCS protein
|
CTD |
PMID:21786383 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases metabolic processing
|
ISO
|
CYP2B6 protein results in increased metabolism of Propofol
|
CTD |
PMID:15769884 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Dio3os
|
DIO3 opposite strand upstream RNA
|
decreases expression
|
ISO
|
Propofol results in decreased expression of DIO3OS mRNA
|
CTD |
PMID:35238236 |
|
|
|
| G
|
Dlg4
|
discs large MAGUK scaffold protein 4
|
increases expression multiple interactions
|
EXP
|
Propofol results in increased expression of DLG4 protein NUFIP1 protein affects the reaction [Propofol results in increased expression of DLG4 protein]
|
CTD |
PMID:38599287 |
|
NCBI chr10:55,239,397...55,267,780
Ensembl chr10:55,236,869...55,265,839
|
|
| G
|
Dpysl2
|
dihydropyrimidinase-like 2
|
increases phosphorylation multiple interactions
|
EXP
|
Propofol results in increased phosphorylation of DPYSL2 protein Dexmedetomidine inhibits the reaction [Propofol results in increased phosphorylation of DPYSL2 protein]
|
CTD |
PMID:31187143 |
|
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065
|
|
| G
|
Edn1
|
endothelin 1
|
decreases expression multiple interactions
|
EXP ISO
|
Propofol results in decreased expression of EDN1 protein Propofol inhibits the reaction [EDN1 protein affects the transport of Calcium]
|
CTD |
PMID:9138053 PMID:17470888 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions
|
ISO
|
[Propofol results in increased susceptibility to STA 9090] which results in decreased expression of EGFR protein
|
CTD |
PMID:24784839 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Ephb2
|
Eph receptor B2
|
increases expression
|
ISO
|
Propofol results in increased expression of EPHB2 mRNA
|
CTD |
PMID:35953652 |
|
NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:154,179,065...154,360,615
|
|
| G
|
Ewsr1
|
EWS RNA-binding protein 1
|
increases expression
|
ISO
|
Propofol results in increased expression of EWSR1 mRNA
|
CTD |
PMID:35953652 |
|
NCBI chr14:84,179,413...84,208,149
Ensembl chr14:84,179,618...84,208,095
|
|
| G
|
Fam95c
|
family with sequence similarity 95 member C
|
decreases expression
|
ISO
|
Propofol results in decreased expression of FAM95C mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr17:59,376,110...59,416,150
Ensembl chr17:59,376,114...59,415,809
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
increases expression
|
ISO
|
Propofol results in increased expression of FAS protein
|
CTD |
PMID:21786383 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Fendrr
|
FOXF1 adjacent non-coding developmental regulatory RNA
|
decreases expression
|
ISO
|
Propofol results in decreased expression of FENDRR mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr19:66,035,910...66,061,466
Ensembl chr19:66,036,856...66,044,268
|
|
| G
|
Fn1
|
fibronectin 1
|
increases expression
|
ISO
|
Propofol results in increased expression of FN1 mRNA
|
CTD |
PMID:35953652 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases expression
|
EXP
|
Lidocaine inhibits the reaction [Propofol results in increased expression of FOS protein] Propofol results in increased expression of FOS mRNA; Propofol results in increased expression of FOS protein
|
CTD |
PMID:10781476 PMID:17136530 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Foxo1
|
forkhead box O1
|
multiple interactions increases expression
|
ISO
|
FOXO1 protein affects the reaction [Propofol results in increased expression of LINC01133 mRNA] Propofol results in increased expression of FOXO1 mRNA; Propofol results in increased expression of FOXO1 protein
|
CTD |
PMID:38146619 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
| G
|
Gabra1
|
gamma-aminobutyric acid type A receptor subunit alpha 1
|
multiple interactions
|
ISO EXP
|
[Propofol co-treated with Pentobarbital] promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; delta-hexachlorocyclohexane inhibits the reaction [Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]]; Propofol affects the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol affects the reaction [Muscimol binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB1 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA1 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA1 protein binds to GABRB3 binds to GABRG2 protein alternative form] Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]; Propofol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2]
|
CTD |
PMID:9316872 PMID:10049148 PMID:11399263 PMID:12939268 PMID:22029276 PMID:29038840 More...
|
|
NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442
|
|
| G
|
Gabra2
|
gamma-aminobutyric acid type A receptor subunit alpha 2
|
multiple interactions
|
ISO
|
Propofol results in increased activity of [GABRA2 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB3 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB3]
|
CTD |
PMID:29038840 |
|
NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,450,683...37,587,457
|
|
| G
|
Gabra4
|
gamma-aminobutyric acid type A receptor subunit alpha 4
|
increases expression
|
ISO
|
Propofol results in increased expression of GABRA4 mRNA
|
CTD |
PMID:16733821 |
|
NCBI chr14:36,944,747...37,021,652
Ensembl chr14:36,944,388...37,021,648
|
|
| G
|
Gabra6
|
gamma-aminobutyric acid type A receptor subunit alpha6
|
multiple interactions
|
ISO
|
Propofol results in increased activity of [GABRA6 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA6 protein binds to GABRB3 binds to GABRG2 protein alternative form]
|
CTD |
PMID:29038840 |
|
NCBI chr10:27,311,965...27,327,337
Ensembl chr10:27,311,979...27,327,234
|
|
| G
|
Gabrb1
|
gamma-aminobutyric acid type A receptor subunit beta1
|
multiple interactions
|
ISO
|
Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB1 binds to GABRG2 protein alternative form]
|
CTD |
PMID:10049148 PMID:29038840 |
|
NCBI chr14:36,434,339...36,917,920
Ensembl chr14:36,434,352...36,902,893
|
|
| G
|
Gabrb2
|
gamma-aminobutyric acid type A receptor subunit beta 2
|
affects response to substance multiple interactions
|
EXP ISO
|
GABRB2 protein affects the susceptibility to Propofol Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]; Propofol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] Propofol results in increased activity of [GABRA1 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA6 protein binds to GABRB2 binds to GABRG2 protein alternative form]
|
CTD |
PMID:11399263 PMID:12939268 PMID:29038840 |
|
NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171
|
|
| G
|
Gabrb3
|
gamma-aminobutyric acid type A receptor subunit beta 3
|
multiple interactions
|
ISO
|
[Propofol co-treated with Pentobarbital] promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; delta-hexachlorocyclohexane inhibits the reaction [Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]]; Propofol affects the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol affects the reaction [Muscimol binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB3 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB3 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB3]; Propofol results in increased activity of [GABRA6 protein binds to GABRB3 binds to GABRG2 protein alternative form]
|
CTD |
PMID:9316872 PMID:22029276 PMID:29038840 |
|
NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:117,431,842...117,836,725
|
|
| G
|
Gabre
|
gamma-aminobutyric acid type A receptor subunit epsilon
|
multiple interactions decreases response to substance
|
ISO EXP
|
Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]] GABRE protein results in decreased susceptibility to Propofol
|
CTD |
PMID:9039914 PMID:10049148 |
|
NCBI chr X:155,102,078...155,120,821
Ensembl chr X:155,102,083...155,120,735
|
|
| G
|
Gabrg2
|
gamma-aminobutyric acid type A receptor subunit gamma 2
|
multiple interactions
|
ISO EXP
|
[Propofol co-treated with Pentobarbital] promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; delta-hexachlorocyclohexane inhibits the reaction [Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]]; Propofol affects the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol affects the reaction [Muscimol binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB1 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA1 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA1 protein binds to GABRB3 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB3 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA6 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA6 protein binds to GABRB3 binds to GABRG2 protein alternative form] Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]; Propofol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2]
|
CTD |
PMID:9316872 PMID:10049148 PMID:11399263 PMID:12939268 PMID:22029276 PMID:29038840 More...
|
|
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523
|
|
| G
|
Gas5
|
growth arrest specific 5
|
increases expression
|
ISO
|
Propofol results in increased expression of GAS5 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr13:75,836,963...75,840,284
|
|
| G
|
Gcnt4
|
glucosaminyl (N-acetyl) transferase 4
|
increases expression
|
ISO
|
Propofol results in increased expression of GCNT4 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 2:29,987,944...30,017,708
Ensembl chr 2:29,984,327...30,017,982
|
|
| G
|
Glud1
|
glutamate dehydrogenase 1
|
decreases expression
|
ISO
|
Propofol results in decreased expression of GLUD1 protein
|
CTD |
PMID:36207479 |
|
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210
|
|
| G
|
Gnai2
|
G protein subunit alpha i2
|
decreases expression
|
ISO
|
Propofol results in decreased expression of GNAI2 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622
|
|
| G
|
Gnrh1
|
gonadotropin releasing hormone 1
|
increases expression multiple interactions
|
ISO
|
Propofol results in increased expression of GNRH1 mRNA Lipopolysaccharides promotes the reaction [Propofol results in increased expression of GNRH1 mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr15:46,147,878...46,152,086
Ensembl chr15:46,148,301...46,148,977 Ensembl chr15:46,148,301...46,148,977
|
|
| G
|
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2
|
increases expression multiple interactions
|
EXP
|
Propofol results in increased expression of GRIA2 protein alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Propofol results in increased expression of GRIA2 protein]
|
CTD |
PMID:28663055 |
|
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
|
|
| G
|
Grin2a
|
glutamate ionotropic receptor NMDA type subunit 2A
|
affects response to substance
|
ISO
|
GRIN2A protein affects the susceptibility to Propofol
|
CTD |
PMID:15731593 |
|
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions
|
EXP
|
Dexmedetomidine inhibits the reaction [Propofol results in decreased phosphorylation of and results in increased activity of GSK3B protein]; Propofol results in decreased phosphorylation of and results in increased activity of GSK3B protein
|
CTD |
PMID:31187143 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
H19
|
H19 imprinted maternally expressed transcript
|
decreases expression
|
ISO
|
Propofol results in decreased expression of H19 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 1:207,160,175...207,162,851
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
multiple interactions
|
ISO
|
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of HGF mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
multiple interactions decreases expression
|
ISO
|
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of HIF1A mRNA]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of HIF1A protein] Propofol results in decreased expression of HIF1A protein
|
CTD |
PMID:21307008 PMID:36207479 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions
|
EXP
|
Propofol results in increased expression of HMOX1 protein HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; Propofol inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]; Propofol inhibits the reaction [Streptozocin results in decreased activity of HMOX1 protein]; Propofol promotes the reaction [Glucose results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Propofol inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Propofol promotes the reaction [Glucose results in increased expression of HMOX1 protein]]
|
CTD |
PMID:21468576 PMID:24810525 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hpse
|
heparanase
|
increases expression multiple interactions
|
ISO
|
Propofol results in increased expression of HPSE mRNA Lipopolysaccharides promotes the reaction [Propofol results in increased expression of HPSE mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr14:9,200,971...9,241,377
Ensembl chr14:9,188,275...9,241,754
|
|
| G
|
Htatip2
|
HIV-1 Tat interactive protein 2
|
multiple interactions increases expression
|
ISO
|
Lipopolysaccharides promotes the reaction [Propofol results in increased expression of HTATIP2 mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:108,605,811...108,624,815
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
increases expression
|
ISO
|
Propofol results in increased expression of IGF1 mRNA
|
CTD |
PMID:35953652 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igsf9b
|
immunoglobulin superfamily, member 9B
|
decreases expression
|
ISO
|
Propofol results in decreased expression of IGSF9B mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 8:33,971,779...34,027,390
Ensembl chr 8:33,971,779...34,018,128
|
|
| G
|
Il10
|
interleukin 10
|
increases expression
|
ISO
|
Propofol results in increased expression of IL10 protein
|
CTD |
PMID:17032661 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il18
|
interleukin 18
|
multiple interactions increases expression
|
ISO
|
Lipopolysaccharides promotes the reaction [Propofol results in increased expression of IL18 mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions decreases expression
|
ISO
|
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] Propofol results in decreased expression of IL1B mRNA
|
CTD |
PMID:35953652 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il2ra
|
interleukin 2 receptor subunit alpha
|
decreases secretion
|
ISO
|
Propofol results in decreased secretion of IL2RA protein
|
CTD |
PMID:16119599 |
|
NCBI chr17:71,759,802...71,808,475
Ensembl chr17:71,759,802...71,808,507
|
|
| G
|
Il6
|
interleukin 6
|
decreases expression multiple interactions
|
ISO
|
Propofol results in decreased expression of IL6 protein Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
|
CTD |
PMID:17032661 PMID:21307008 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Jak2
|
Janus kinase 2
|
decreases phosphorylation
|
ISO
|
Propofol decreases phosphorylation of JAK2 protein in colon epithelium
|
RGD |
PMID:32386021 |
RGD:125097524 |
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
EXP
|
Propofol results in increased expression of JUN mRNA
|
CTD |
PMID:10781476 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Kng1
|
kininogen 1
|
multiple interactions
|
ISO
|
[Propofol co-treated with Pharmaceutical Vehicles] results in increased expression of KNG1 protein modified form; [Triglycerides co-treated with Propofol] results in increased expression of KNG1 protein modified form; Lidocaine inhibits the reaction [[Propofol co-treated with Pharmaceutical Vehicles] results in increased expression of KNG1 protein modified form]; nafamostat inhibits the reaction [[Propofol co-treated with Pharmaceutical Vehicles] results in increased expression of KNG1 protein modified form]
|
CTD |
PMID:10655909 PMID:15983144 |
|
NCBI chr11:91,317,354...91,340,148
Ensembl chr11:91,317,355...91,340,148
|
|
| G
|
Ldha
|
lactate dehydrogenase A
|
increases activity
|
ISO
|
Propofol increases activity of LDHA protein in colon epithelium
|
RGD |
PMID:32386021 |
RGD:125097524 |
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
|
|
| G
|
Lrcol1
|
leucine rich colipase-like 1
|
decreases expression
|
ISO
|
Propofol results in decreased expression of LRCOL1 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr12:51,985,786...51,999,282
Ensembl chr12:51,985,814...51,997,688
|
|
| G
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1
|
increases expression
|
ISO
|
Propofol results in increased expression of LRG1 mRNA
|
CTD |
PMID:21786383 |
|
NCBI chr 9:1,034,691...1,036,937
Ensembl chr 9:1,034,679...1,037,337
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions
|
ISO
|
MIR138 promotes the reaction [Propofol results in increased lipidation of and results in increased localization of MAP1LC3B protein]; Propofol results in increased lipidation of and results in increased localization of MAP1LC3B protein
|
CTD |
PMID:39441175 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map2k1
|
mitogen activated protein kinase kinase 1
|
multiple interactions
|
ISO
|
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAP2K1 protein]
|
CTD |
PMID:19573522 |
|
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
|
|
| G
|
Map2k2
|
mitogen activated protein kinase kinase 2
|
multiple interactions
|
ISO
|
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAP2K2 protein]
|
CTD |
PMID:19573522 |
|
NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions decreases phosphorylation
|
ISO EXP
|
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein] Propofol results in decreased phosphorylation of MAPK1 protein PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of MAPK1 protein]
|
CTD |
PMID:19573522 PMID:31257496 PMID:36207479 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions decreases phosphorylation
|
ISO EXP
|
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK3 protein] Propofol results in decreased phosphorylation of MAPK3 protein PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of MAPK3 protein]
|
CTD |
PMID:19573522 PMID:31257496 PMID:36207479 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Met
|
MET proto-oncogene, receptor tyrosine kinase
|
multiple interactions increases expression
|
ISO
|
Lipopolysaccharides promotes the reaction [Propofol results in increased expression of MET mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821
|
|
| G
|
Mgat5
|
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase
|
multiple interactions increases expression
|
ISO
|
Lipopolysaccharides promotes the reaction [Propofol results in increased expression of MGAT5 mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr13:41,228,327...41,516,462
Ensembl chr13:41,228,360...41,516,461
|
|
| G
|
Mir1224
|
microRNA 1224
|
increases expression
|
EXP
|
Propofol results in increased expression of MIR1224 mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr11:93,811,291...93,811,375
|
|
| G
|
Mir138-1
|
microRNA 138-1
|
increases expression multiple interactions
|
ISO
|
Propofol results in increased expression of MIR138 MIR138 promotes the reaction [Propofol results in decreased expression of SIRT1 protein]; MIR138 promotes the reaction [Propofol results in decreased expression of SQSTM1 protein]; MIR138 promotes the reaction [Propofol results in increased expression of BECN1 protein]; MIR138 promotes the reaction [Propofol results in increased lipidation of and results in increased localization of MAP1LC3B protein]
|
CTD |
PMID:39441175 |
|
NCBI chr 8:131,178,434...131,178,532
Ensembl chr 8:131,178,434...131,178,532
|
|
| G
|
Mir146a
|
microRNA 146a
|
decreases expression
|
EXP
|
Propofol results in decreased expression of MIR146A mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr10:28,349,996...28,350,090
|
|
| G
|
Mir146b
|
microRNA 146b
|
decreases expression
|
EXP
|
Propofol results in decreased expression of MIR146B mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:255,144,860...255,144,947
|
|
| G
|
Mir155
|
microRNA 155
|
decreases expression
|
EXP
|
Propofol results in decreased expression of MIR155 mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178
|
|
| G
|
Mir186
|
microRNA 186
|
multiple interactions
|
ISO
|
Propofol affects the reaction [LINC01133 affects the expression of MIR186 mRNA]; Propofol inhibits the reaction [MIR186 results in decreased expression of NR3C2 protein]
|
CTD |
PMID:38146619 |
|
NCBI chr 2:249,241,650...249,241,735
Ensembl chr 2:249,241,650...249,241,735
|
|
| G
|
Mir221
|
microRNA 221
|
decreases expression
|
EXP
|
Propofol results in decreased expression of MIR221 mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr X:6,023,182...6,023,290
Ensembl chr X:6,023,182...6,023,290
|
|
| G
|
Mir222
|
microRNA 222
|
decreases expression
|
EXP
|
Propofol results in decreased expression of MIR222 mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr X:6,022,621...6,022,723
Ensembl chr X:6,022,621...6,022,723
|
|
| G
|
Mir27b
|
microRNA 27b
|
increases expression
|
EXP
|
Propofol results in increased expression of MIR27B mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr17:1,819,147...1,819,243
|
|
| G
|
Mir3473
|
microRNA 3473
|
increases expression
|
EXP
|
Propofol results in increased expression of MIR3473 mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr13:42,051,691...42,051,757
Ensembl chr13:42,051,691...42,051,757
|
|
| G
|
Mir378
|
microRNA 378
|
increases expression
|
EXP
|
Propofol results in increased expression of MIR378 mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr18:57,128,922...57,128,986
|
|
| G
|
Mir6215
|
microRNA 6215
|
increases expression
|
EXP
|
Propofol results in increased expression of MIR6215 mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr 5:157,133,945...157,134,011
|
|
| G
|
Mir665
|
microRNA 665
|
increases expression
|
EXP
|
Propofol results in increased expression of MIR665 mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr 6:134,321,679...134,321,772
Ensembl chr 6:134,321,679...134,321,772
|
|
| G
|
Mir99a
|
microRNA 99a
|
increases expression
|
EXP
|
Propofol results in increased expression of MIR99A mRNA
|
CTD |
PMID:26254736 |
|
NCBI chr11:29,687,392...29,687,472
Ensembl chr11:29,687,392...29,687,472
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
decreases expression
|
ISO
|
Propofol results in decreased expression of MKI67 protein
|
CTD |
PMID:36207479 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
multiple interactions decreases expression
|
ISO
|
Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of MMP2 mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp24os
|
MMP24 opposite strand
|
decreases expression
|
ISO
|
Propofol results in decreased expression of MMP24OS mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 3:164,783,060...164,784,573
Ensembl chr 3:164,783,060...164,784,573
|
|
| G
|
Mmp7
|
matrix metallopeptidase 7
|
multiple interactions increases expression
|
ISO
|
Lipopolysaccharides promotes the reaction [Propofol results in increased expression of MMP7 mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755
|
|
| G
|
Mpc1
|
mitochondrial pyruvate carrier 1
|
decreases expression
|
ISO
|
Propofol results in decreased expression of MPC1 protein
|
CTD |
PMID:36207479 |
|
NCBI chr 1:54,985,305...54,996,979
Ensembl chr 1:54,985,301...54,997,064
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
decreases phosphorylation multiple interactions
|
ISO
|
Propofol results in decreased phosphorylation of MTOR protein CASC9 protein inhibits the reaction [Propofol results in decreased phosphorylation of MTOR protein]
|
CTD |
PMID:35238236 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
EXP
|
Propofol inhibits the reaction [Halothane results in increased phosphorylation of NFKBIA protein]
|
CTD |
PMID:16965849 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Ngf
|
nerve growth factor
|
multiple interactions
|
EXP
|
Bicuculline inhibits the reaction [Propofol inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein]]; Propofol inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein]
|
CTD |
PMID:11991087 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
EXP ISO
|
Propofol inhibits the reaction [Halothane results in increased expression of NOS2 protein] Propofol inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA]; Propofol inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]
|
CTD |
PMID:16965849 PMID:19573522 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nppa
|
natriuretic peptide A
|
multiple interactions
|
EXP
|
HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]
|
CTD |
PMID:24810525 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
Npy
|
neuropeptide Y
|
multiple interactions
|
EXP
|
Propofol inhibits the reaction [Potassium results in increased secretion of NPY protein]
|
CTD |
PMID:29320738 |
|
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310
|
|
| G
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2
|
multiple interactions
|
ISO
|
Propofol inhibits the reaction [MIR186 results in decreased expression of NR3C2 protein]
|
CTD |
PMID:38146619 |
|
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078
|
|
| G
|
Nufip1
|
nuclear FMR1 interacting protein 1
|
multiple interactions affects response to substance
|
EXP ISO
|
NUFIP1 protein affects the reaction [Propofol results in decreased expression of BCL2 protein]; NUFIP1 protein affects the reaction [Propofol results in increased expression of BAX protein]; NUFIP1 protein affects the reaction [Propofol results in increased expression of DLG4 protein]; NUFIP1 protein inhibits the reaction [Propofol results in increased cleavage of CASP3 protein] [NUFIP1 affects the susceptibility to Propofol] which affects the cleavage of CASP protein; [NUFIP1 affects the susceptibility to Propofol] which affects the expression of BAX protein; [NUFIP1 affects the susceptibility to Propofol] which affects the expression of BCL2 protein
|
CTD |
PMID:38599287 |
|
NCBI chr15:57,838,864...57,869,597
Ensembl chr15:57,837,608...57,869,594
|
|
| G
|
Or5ac16
|
olfactory receptor family 5 subfamily AC member 16
|
decreases expression
|
ISO
|
Propofol results in decreased expression of OR5AC16 mRNA
|
CTD |
PMID:21786383 |
|
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
ISO
|
[Propofol results in increased susceptibility to STA 9090] which results in increased cleavage of PARP1 protein
|
CTD |
PMID:24784839 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
decreases expression multiple interactions
|
ISO
|
Propofol results in decreased expression of PCNA protein CASC9 protein inhibits the reaction [Propofol results in decreased expression of PCNA protein]
|
CTD |
PMID:35238236 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pea15
|
proliferation and apoptosis adaptor protein 15
|
decreases expression multiple interactions
|
EXP
|
Propofol results in decreased expression of PEA15 mRNA; Propofol results in decreased expression of PEA15 protein PEA15 protein inhibits the reaction [Propofol results in decreased expression of BCL2 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased expression of CASP3 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased expression of RPS6KA3 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of CREB1 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of MAPK1 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of MAPK3 protein]; PEA15 protein inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; PEA15 protein inhibits the reaction [Propofol results in increased expression of BAX protein]
|
CTD |
PMID:31257496 |
|
NCBI chr13:87,190,189...87,199,811
Ensembl chr13:87,187,295...87,199,859
|
|
| G
|
Pkd1l3
|
polycystin 1 like 3, transient receptor potential channel interacting
|
decreases expression
|
ISO
|
Propofol results in decreased expression of PKD1L3 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr19:54,494,529...54,559,596
Ensembl chr19:54,495,243...54,559,546
|
|
| G
|
Pla2g2c
|
phospholipase A2, group IIC
|
increases expression
|
ISO
|
Propofol results in increased expression of PLA2G2C mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 5:156,241,142...156,262,368
Ensembl chr 5:156,242,451...156,264,676
|
|
| G
|
Pln
|
phospholamban
|
decreases phosphorylation
|
EXP
|
Propofol results in decreased phosphorylation of PLN protein
|
CTD |
PMID:27495954 |
|
NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241
|
|
| G
|
Pnn
|
pinin, desmosome associated protein
|
multiple interactions decreases expression
|
ISO
|
Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of PNN mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr 6:82,493,032...82,501,345
Ensembl chr 6:82,492,978...82,501,933
|
|
| G
|
Prkcd
|
protein kinase C, delta
|
multiple interactions
|
EXP
|
Propofol inhibits the reaction [Doxorubicin results in increased cleavage of PRKCD protein]
|
CTD |
PMID:22015447 |
|
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839
|
|
| G
|
Prl
|
prolactin
|
increases secretion
|
ISO
|
Propofol results in increased secretion of PRL protein
|
CTD |
PMID:18482853 |
|
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
|
|
| G
|
Pten
|
phosphatase and tensin homolog
|
increases expression multiple interactions
|
ISO
|
Propofol results in increased expression of PTEN protein CASC9 protein inhibits the reaction [Propofol results in increased expression of PTEN protein]
|
CTD |
PMID:35238236 |
|
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
| G
|
Raf1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
multiple interactions
|
ISO
|
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of RAF1 protein]
|
CTD |
PMID:19573522 |
|
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813
|
|
| G
|
Ren
|
renin
|
multiple interactions
|
ISO
|
[Propofol co-treated with desflurane] results in increased expression of REN protein
|
CTD |
PMID:8017643 |
|
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543
|
|
| G
|
Rnu12
|
RNA, U12 small nuclear
|
decreases expression
|
ISO
|
Propofol results in decreased expression of RNU12 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 7:116,183,590...116,183,740
Ensembl chr 7:116,183,590...116,183,740
|
|
| G
|
Rorb
|
RAR-related orphan receptor B
|
multiple interactions decreases expression
|
ISO
|
Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of RORB mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr 1:225,790,216...225,970,973
Ensembl chr 1:225,790,216...225,970,973
|
|
| G
|
Rps6ka3
|
ribosomal protein S6 kinase A3
|
decreases expression multiple interactions
|
EXP
|
Propofol results in decreased expression of RPS6KA3 protein PEA15 protein inhibits the reaction [Propofol results in decreased expression of RPS6KA3 protein]
|
CTD |
PMID:31257496 |
|
NCBI chr X:39,325,926...39,432,017
Ensembl chr X:39,325,926...39,433,678
|
|
| G
|
Rpsa
|
ribosomal protein SA
|
increases expression multiple interactions
|
ISO
|
Propofol results in increased expression of RPSA mRNA Lipopolysaccharides promotes the reaction [Propofol results in increased expression of RPSA mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737
|
|
| G
|
Ryr2
|
ryanodine receptor 2
|
decreases phosphorylation
|
EXP
|
Propofol results in decreased phosphorylation of RYR2 protein
|
CTD |
PMID:27495954 |
|
NCBI chr17:63,081,527...63,667,141
Ensembl chr17:63,081,527...63,666,705
|
|
| G
|
Serpinf1
|
serpin family F member 1
|
increases expression
|
ISO
|
Propofol results in increased expression of SERPINF1 protein
|
CTD |
PMID:36207479 |
|
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,748,506...60,760,898
|
|
| G
|
Set
|
Set nuclear proto-oncogene
|
decreases expression multiple interactions
|
ISO
|
Propofol results in decreased expression of SET mRNA Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of SET mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr 3:33,732,319...33,743,433
|
|
| G
|
Sirt1
|
sirtuin 1
|
decreases expression multiple interactions
|
ISO
|
Propofol results in decreased expression of SIRT1 protein MIR138 promotes the reaction [Propofol results in decreased expression of SIRT1 protein]
|
CTD |
PMID:39441175 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Slc1a1
|
solute carrier family 1 member 1
|
multiple interactions
|
EXP
|
[Tetradecanoylphorbol Acetate co-treated with Propofol] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of SLC1A1 protein]
|
CTD |
PMID:17382927 |
|
NCBI chr 1:235,963,455...236,043,572
Ensembl chr 1:235,963,437...236,045,469
|
|
| G
|
Slc2a1
|
solute carrier family 2 member 1
|
decreases expression
|
ISO
|
Propofol results in decreased expression of SLC2A1 protein
|
CTD |
PMID:36207479 |
|
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742
|
|
| G
|
Slc38a3
|
solute carrier family 38, member 3
|
decreases expression
|
ISO
|
Propofol results in decreased expression of SLC38A3 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 8:117,202,534...117,220,310
Ensembl chr 8:117,202,536...117,218,630
|
|
| G
|
Slc6a3
|
solute carrier family 6 member 3
|
decreases expression
|
ISO
|
Propofol results in decreased expression of SLC6A3 protein
|
CTD |
PMID:32612007 |
|
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962
|
|
| G
|
Slc7a11
|
solute carrier family 7 member 11
|
decreases expression multiple interactions
|
EXP
|
Propofol results in decreased expression of SLC7A11 protein alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Propofol results in decreased expression of SLC7A11 protein]
|
CTD |
PMID:28663055 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
|
|
| G
|
Smad2
|
SMAD family member 2
|
multiple interactions decreases expression
|
ISO
|
Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of SMAD2 mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
|
|
| G
|
Snap25
|
synaptosome associated protein 25
|
multiple interactions
|
EXP
|
SNAP25 protein affects the reaction [Propofol affects the localization of STX1A protein]
|
CTD |
PMID:29320738 |
|
NCBI chr 3:144,494,579...144,576,449
Ensembl chr 3:144,494,595...144,576,448
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions
|
EXP
|
Propofol inhibits the reaction [Doxorubicin results in decreased expression of SOD1 protein]
|
CTD |
PMID:22015447 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
increases expression multiple interactions
|
EXP
|
Propofol results in increased expression of SOD2 protein Propofol inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein]
|
CTD |
PMID:21468576 PMID:22015447 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sqstm1
|
sequestosome 1
|
decreases expression multiple interactions
|
ISO
|
Propofol results in decreased expression of SQSTM1 protein MIR138 promotes the reaction [Propofol results in decreased expression of SQSTM1 protein]
|
CTD |
PMID:39441175 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
| G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
increases expression
|
ISO
|
Propofol results in increased expression of SRC mRNA
|
CTD |
PMID:35953652 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
| G
|
Srd5a2
|
steroid 5 alpha-reductase 2
|
decreases expression
|
ISO
|
Propofol results in decreased expression of SRD5A2 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 6:27,178,089...27,217,588
Ensembl chr 6:27,178,079...27,217,588
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions increases phosphorylation decreases phosphorylation
|
EXP ISO
|
HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]; Propofol promotes the reaction [Streptozocin results in decreased phosphorylation of STAT3 protein]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; zinc protoporphyrin inhibits the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]] Propofol results in increased phosphorylation of STAT3 protein Propofol decreases phosphorylation of STAT3 protein in colon epithelium
|
CTD RGD |
PMID:24810525 PMID:32386021 |
RGD:125097524 |
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Stx1a
|
syntaxin 1A
|
multiple interactions affects localization
|
EXP
|
Propofol inhibits the reaction [barium chloride affects the localization of STX1A protein]; SNAP25 protein affects the reaction [Propofol affects the localization of STX1A protein]; STX1A protein modified form inhibits the reaction [Propofol affects the localization of STX1A protein]; STX1A protein modified form inhibits the reaction [Propofol inhibits the reaction [barium chloride affects the localization of STX1A protein]]
|
CTD |
PMID:29320738 |
|
NCBI chr12:27,278,517...27,306,547
Ensembl chr12:27,278,517...27,306,471
|
|
| G
|
Tdh
|
L-threonine dehydrogenase
|
decreases expression
|
ISO
|
Propofol results in decreased expression of TDH mRNA
|
CTD |
PMID:21786383 |
|
NCBI chr15:41,915,766...41,929,307
Ensembl chr15:41,915,766...41,929,307
|
|
| G
|
Th
|
tyrosine hydroxylase
|
decreases expression
|
ISO
|
Propofol results in decreased expression of TH protein
|
CTD |
PMID:32612007 |
|
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227
|
|
| G
|
Timp2
|
TIMP metallopeptidase inhibitor 2
|
increases expression multiple interactions
|
ISO
|
Propofol results in increased expression of TIMP2 mRNA; Propofol results in increased expression of TIMP2 protein Lipopolysaccharides promotes the reaction [Propofol results in increased expression of TIMP2 mRNA]
|
CTD |
PMID:35953652 |
|
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
|
|
| G
|
Tincr
|
TINCR ubiquitin domain containing
|
increases expression
|
ISO
|
Propofol results in increased expression of TINCR mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 9:1,476,770...1,477,039 NCBI chr 9:1,474,238...1,476,470
Ensembl chr 9:1,476,147...1,477,238
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
multiple interactions
|
ISO
|
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]; TLR4 protein affects the reaction [Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]
|
CTD |
PMID:19433076 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tmc6
|
transmembrane channel like 6
|
increases expression
|
ISO
|
Propofol results in increased expression of TMC6 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr10:103,480,762...103,498,207
Ensembl chr10:103,480,762...103,497,398
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; TLR4 protein affects the reaction [Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]
|
CTD |
PMID:19433076 PMID:21307008 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tp53
|
tumor protein p53
|
multiple interactions increases expression
|
EXP ISO
|
Propofol inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] Propofol results in increased expression of TP53 protein
|
CTD |
PMID:22015447 PMID:28804952 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Trpc6
|
transient receptor potential cation channel, subfamily C, member 6
|
decreases expression multiple interactions
|
EXP
|
Propofol results in decreased expression of TRPC6 protein 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole promotes the reaction [Propofol results in decreased expression of TRPC6 protein]; hyperforin inhibits the reaction [Propofol results in decreased expression of TRPC6 protein]
|
CTD |
PMID:36640868 |
|
NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:14,043,877...14,149,304
|
|
| G
|
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C
|
increases glucuronidation
|
EXP
|
UGT1A7 protein results in increased glucuronidation of Propofol
|
CTD |
PMID:15502008 |
|
NCBI chr 9:96,187,382...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Ugt1a9
|
UDP glucuronosyltransferase family 1 member A9
|
decreases activity affects metabolic processing increases glucuronidation multiple interactions
|
ISO
|
Propofol results in decreased activity of UGT1A9 protein UGT1A9 protein affects the metabolism of Propofol UGT1A9 protein results in increased glucuronidation of Propofol [Warfarin binds to and affects the activity of UGT1A9 protein] which affects the glucuronidation of Propofol; licochalcone A inhibits the reaction [UGT1A9 protein results in increased glucuronidation of Propofol]; shikonin inhibits the reaction [UGT1A9 protein results in increased glucuronidation of Propofol]; Warfarin affects the reaction [UGT1A9 protein results in increased glucuronidation of Propofol]
|
CTD |
PMID:12756209 PMID:14570768 PMID:15286053 PMID:15378558 PMID:15769885 PMID:15988124 PMID:18816295 PMID:25393417 PMID:26875642 PMID:31128210 More...
|
|
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Uhrf1
|
ubiquitin-like with PHD and ring finger domains 1
|
increases expression
|
ISO
|
Propofol results in increased expression of UHRF1 mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,222,063...1,241,792
|
|
| G
|
Vim
|
vimentin
|
multiple interactions
|
ISO
|
Propofol affects the reaction [LINC01133 affects the expression of VIM protein]
|
CTD |
PMID:38146619 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
| G
|
Xist
|
X inactive specific transcript
|
increases expression
|
ISO
|
Propofol results in increased expression of XIST mRNA
|
CTD |
PMID:35238236 |
|
NCBI chr X:72,540,753...72,558,266
|
|